baber/WOPTO huggingface dataset:
Patent EP-1156039-B1 (EP)
Inventor: OHKUCHI MASAO
IPC: C07D237/24
Filed: 2000-02-25
Granted: 2005-10-05
Abstract: Objects of the invention are to provide compounds having excellent activity against interleukin-1 beta  production and also medicines comprising them as effective ingredients. Pyridazin-3-one derivatives represented by the following formula (1):   <CHEM> wherein Ar<1> represents a substituted or unsubstituted aromatic group, Ar<2> represents a phenyl group having a substituent at least at the 4-position thereof, R<1> represents a linear or branched alkyl group, an alkyl group having a cyclic structure, a substituted or unsubstituted phenyl group or a substituted or unsubstituted phenyl(lower alkyl) group, and R<2> represents a cyano group, a carboxyl group, a (lower alkoxy)carbonyl group, a substituted or unsubstituted lower alkyl group or a substituted or unsubstituted carbamoyl group, or salts thereof; and medicines comprising them as effective ingredients.
Patent EP-1159119-B1 (EP)
Inventor: PENG HONG
IPC: B29C48/06
Filed: 2000-02-24
Granted: 2003-11-12
Abstract: A cross-head die which is comprised of a die body with a flow chamber, a plurality of die cavities, die elements within the die cavities, communication between the die cavities and the flow chamber, a means for individual flow adjustment to each die cavity, and a means for axial motion of the filamentary member(s) through the die elements. The single flow chamber communicates to a plurality of die cavities through individual radial flow ports. The flow chamber is open at one end and closed at the other except for a cleaning hole. Within each of the radial flow ports resides a device for adjusting flow restriction. Within each die cavity is a cylindrical die piston. A gap created between the die piston and the die cavity defines a path for resin flow. The resin flow path is tapered to a point at which the filamentary member exits from a smaller cylindrical bore through the center of the die piston. The resin is deposited on the filamentary member as it moves through the die piston to produce a composite matrix strand.
Patent EP-1227899-B1 (EP)
Inventor: BOULTON GARY
IPC: B21B33/00
Filed: 2000-05-12
Granted: 2005-03-09
Abstract: Vibration damping apparatus (40) includes a body in the form of backup roll balance piston (42) positionable for sliding movement in an enclosure in the form of cavity (44) in the lower backup roll chock (30) of the mill stack (10). The body of the piston is a casing which performs the role of a conventional postion. A damping means is integral with the piston (42) for providing vibration damping of opposing backup roll chocks (24, 30). The damping means is a specially designed absorption system to provide tuned stiffness and damping elements which act in parallel and are located in compartment (46) at an uppermost end or cap of the piston (42). A second vibration absorbent compartment portion (56) of the piston (42) also includes vibration absorbing components. Portion (56) is an integral cap located at the end of the piston (42) in contact with the fluid (52).
Patent EP-1195005-B1 (EP)
Inventor: PERTHOLD RAINER
IPC: H03F1/32
Filed: 2000-05-19
Granted: 2003-04-02
Abstract: L'invention concerne un dispositif pour effectuer une prédistorsion d'un signal de transmission (S1) à transmettre sur une ligne de transmission non linéaire (10). Ce dispositif présente une unité d'estimation (14, 16) servant à déterminer un signal d'erreur (S2') en fonction du signal de transmission (S1) et d'une caractéristique de transmission, déterminée au préalable, de la ligne de transmission non linéaire (10). Ce signal d'erreur (S2') représente une estimation d'une erreur générée par la non linéarité de la ligne de transmission (10). Un élément de dispersion temporelle (18) sert à produire un signal de correction (S3) par élargissement temporel du signal d'erreur (S2'). Une unité de combinaison (20) sert à combiner le signal de transmission (S1) et le signal de correction (S3). L'élargissement temporel du signal d'erreur (S2') a pour effet d'éloigner une partie du signal d'erreur, dans le spectre de fréquence d'un signal de transmission (S4) transmis par la ligne de transmission non linéaire (10), de la gamme de fréquence utile du signal de transmission.
Patent EP-1234812-B1 (EP)
Inventor: ASAKAWA YUJI
IPC: C08J11/26
Filed: 2000-05-24
Granted: 2008-05-21
Abstract: Selon cette invention, un réceptacle fabriqué dans un téréphtalate de polyéthylène est pulvérisé et dégradé en présence d'un catalyseur au moyen d'un solvant tel qu'un alcool ou un glycol afin d'obtenir un téréphtalate bishydroxyalkyle brut. Le téréphtalate bishydroxyalkyle brut est purifié par filtration, par un traitement au charbon actif et un traitement avec une résine échangeuse d'ions. Le téréphtalate bishydroxyalkyle ainsi obtenu est condensé pour produire un réceptacle ou autre moule en téréphtalate de polyéthylène.
Patent EP-1200544-B1 (EP)
Inventor: BRAGULLA SIEGFRIED
IPC: C11D1/722
Filed: 2000-07-22
Granted: 2005-11-09
Abstract: The invention relates to cleaning material formulations and the use thereof in the removal of pigment-containing residues which arise during the production or filling of pharmaceutical or cosmetic preparations. Said formulations are based on one or several consituents with complex-forming properties selected from the following groups: amino carboxylic acids, polyamino acids, P-free carboxylic acids and the salts thereof.
Patent EP-1217918-B1 (EP)
Inventor: THODE JUERGEN
IPC: A47B3/00
Filed: 2000-08-22
Granted: 2003-07-16
Abstract: A table with a pivotable table top for changing between a working position and a stacking position. The table has a table top and a table frame, wherein the table frame has a horizontal beam, at least one support part for supporting the table top and one or more table legs fixedly coupled to the support part, wherein the table top is hinged to the table frame so as to be pivotable about a horizontal pivot axis, and wherein the support part is movable transversely with respect to the pivot axis between the working position and the stacking position or is coupled to the beam so as to be pivotable about a vertical axis. Between the table top and the support part coupling means are provided which effect common pivoting or turning of the table top and of the table leg coupled to the support part.
Patent EP-1224525-B1 (EP)
Inventor: SHARP JONATHAN
IPC: H04M1/72469
Filed: 2000-09-25
Granted: 2003-11-26
Abstract: A portable electronic device is provided comprising a user input device capable of adopting at least three pre-determined positions, each of which enables an associated function to be actuated, and of adopting two pre-determined positions simultaneously. The portable electronic device further comprises a device for presenting information to a user and a processor for receiving inputs from the user input device and altering the operating state of the portable electronic device accordingly. The portable electronic device is operable to scroll through information items presented to a user and the user input device is arranged to present at least two scrolling speeds. A first scrolling speed is selected when the user input device is placed in a first pre-determined position and a second scrolling speed is selected when the user input device is placed in the first pre-determined position and a second predetermined position at the same time.
Patent EP-1227721-B1 (EP)
Inventor: BALKOVEC JAMES M
IPC: C07C69/734
Filed: 2000-10-27
Granted: 2007-04-04
Abstract: This invention relates to novel substituted succinic acid metallo-beta-lactamase inhibitors which are useful potentiators of beta-lactam antibiotics. Accordingly, the present invention provides a method of treating bacterial infections in animals or humans which comprises administering, together with a b-lactam antibiotic, a therapeutically effective amount of a compound of formula I:  including pharmaceutically acceptable salts, prodrugs, anhydrides, and solvates thereof.
Patent EP-1228063-B1 (EP)
Inventor: DUMAS JACQUES P
IPC: A61P31/22
Filed: 2000-09-26
Granted: 2009-02-11
Abstract: La présente invention concerne des pyridines et des pyridazines substituées possédant une activité inhibitrice de l'angiogenèse et une formule structurelle généralisée dans laquelle le noyau contenant A, B, D, E et L est un phényle ou un hétérocycle contenant de l'azote; les groupes X et Y peuvent être l'un des motifs de liaison d'une variété de motifs de liaison définis; R1 et R2 peuvent être des substituants définis indépendants ou peuvent être, ensemble, un pont définissant un noyau; le noyau J peut être un groupe aryle, pyridyle ou cycloalkyle; et les groupes G peuvent être un substituant défini parmi une variété de substituants définis.  L'invention se rapporte également à des compositions pharmaceutiques contenant les substances précitées, et à des procédés permettant de traiter, à l'aide des substances précitées, un mammifère présentant un état caractérisé par une angiogenèse anormale ou par des processus d'hyperperméabilité.
Patent EP-1237772-B1 (EP)
Inventor: GERS HORST
IPC: B60R19/34
Filed: 2000-11-02
Granted: 2004-04-14
Abstract: The device for energy consumption for a rail vehicle used in urban transport contains an energy consumption component containing a metal foam core (1) and a structural part (3) for vehicle-side fixture of the component. The metal foam core in its production is provided with maximum energy accommodation properties, for its power and movement function, end power and energy - time function.
Patent EP-1259844-B1 (EP)
Inventor: FLANDERS DALE C
IPC: G02B7/00
Filed: 2000-11-14
Granted: 2005-11-02
Abstract: Des structures de montage et d'alignement pour des composants optiques permettent aux composants optiques d'être connectés à un banc optique et puis alignés, c'est-à-dire, passivement ou activement, selon des processus de fabrication ou de calibrage subséquent ou de recalibrage, d'alignement ou de réalignement. Les structures comprennent des portions de quasi-extrusion. Cette portion est dite de 'quasi-extrusion' dans le sens où elle a une section transversale pratiquement constante dans une direction de l'axe z, comme on en obtiendrait une dans un processus de fabrication par extrusion. Les structures comprennent, en outre, au moins une base dotée d'une surface s'étendant latéralement, et une interface du composant optique. Au moins une armature relie l'interface de composant optique à la base. Dans un mode de réalisation préféré, la surface de base peut être fixée sur un banc optique.
Patent EP-1142705-B1 (EP)
Inventor: SCHORNING MARTIN
IPC: B32B27/36
Filed: 2001-03-28
Granted: 2007-11-07
Abstract: In a transparent multilayer composite including an inner layer(s) of transparent plastics and two outer layers of glass, a partially crystalline film of at least 40% transparency, amorphous plastics films and transparent coatings for mechanical protection, the inner and outer layers are separated by a glass or liquid layer, a transparent film, a transparent adhesive later, or a contact layer.
Patent EP-1162195-B1 (EP)
Inventor: VOGT UWE DR
IPC: C08L71/00
Filed: 2001-05-29
Granted: 2006-05-03
Abstract: Novel sulfuric acid esters are claimed. Sulfuric acid esters (I) are of formula (1). -CH2CH2O-(CH2CH2O)n-N(X)-(CH2CH2O)m-Y (2) -(CH2CH(R<4>)O)p-Z (3) R<1> = 1-30C aliphatic group; R<2> = formula (2); R<3> = formula (3); X = 4-24C aliphatic group; Y = H or SO2(OM); M = H, alkali metal, ammonium, mono-, di-, tri or tetra (2-6C alkanol) ammonium; Z = H, methyl, ethyl or SO2(OM); n = 0-30; m = 1-29; p = 4-35; a, b, c = 0-2; a+b+c = 2. Independent claims are included for: (i) a mixture (II) of sulfuric acid esters prepared by reaction of sulfuryl chloride with a mixture of alcohols R<1>OH, R<2>OH and R<3>OH; and (ii) organic or aqueous-organic formulations containing 25-70 wt.% of the sulfuric acid ester (I) or mixture (II). Y = H; Z = H, methyl or ethyl.
Patent EP-1202147-B1 (EP)
Inventor: NOELL MATTHIAS
IPC: G05D19/02
Filed: 2001-10-09
Granted: 2004-12-22
Abstract: The method involves superimposing at least one of the discrete frequency components of the mechanical vibration (2) with an essentially harmonic torque (14) of equal frequency with a defined amplitude and phase by an actuator (11) and independently of the other frequency components so that the vibration amplitude at this frequency is reduced. Independent claims are also included for the following: a group of printing mechanisms and a printing machine.
Patent EP-1343529-B1 (EP)
Inventor: LICHTENBERGER LENARD
IPC: A61P1/04
Filed: 2001-12-19
Granted: 2008-11-19
Abstract: A novel pharmaceutical composition is provided by which nonsteroidal anti-inflammatory drugs (NSAIDs) are added directly to phospholipid-containing oil such as lecithin oils or to a bio-compatible oil to which an phospholipid has been added to make a NSAID-containing formulation that possess low gastrointestinal (GI) toxicity and enhanced therapeutic activity to treat or prevent inflammation, pain, fever, platelet aggregation, tissue ulcerations and/or other tissue disorders. The composition of the invention are in the form of a non-aqueous solution, paste, suspension, dispersion, colloidal suspension or in the form of an aqueous emulsion or microemulstion for internal, oral, direct or topical administration.
Patent EP-1289184-B1 (EP)
Inventor: BARRETT PAUL
IPC: H04L1/24
Filed: 2001-08-15
Granted: 2009-04-15
Abstract: This invention relates to the measurement of the accuracy of a communication channel. The invention provides a method and apparatus for determining channel degradation information for a communications channel, in which a known data sequence is generated within a transmitter; a coded data sequence based on the known data sequence is transmitted using the transmission channel; said known data sequence is generated within the receiver; and the known data sequence generated within the receiver is compared with a decoded data sequence based on data received via the channel to provide said channel degradation information; wherein a source encoder in the transmitter has the ability to generate a predetermined output data sequence in response to a predetermined input data sequence; the known data sequence is generated within the transmitter and within the receiver in dependence upon the predetermined output data sequence; and the decoded data sequence is measured prior to source decoding in the receiver. <IMAGE>
Patent EP-1120107-B1 (EP)
Inventor: CASTELLI DOMINIQUE
IPC: A23L33/15
Filed: 2001-01-25
Granted: 2005-07-20
Abstract: The present invention relates to the use of a composition comprising an oil with a high content of essential fatty acids of  omega 3 and omega 6 type, preferably blackcurrant seed oil, and at least one compound selected from  beta -carotene, lycopene, tocopherol and its derivatives, tocotrienols and their derivatives, ascorbic acid and nicotinamide, as a nutritional supplement intended for preventing and/or combating the harmful effects of xenobiotics on the skin, in particular on the skin's immune system.
Patent EP-1216634-B1 (EP)
Inventor: TANTER WILFRID
IPC: A47C27/00
Filed: 2001-12-19
Granted: 2005-11-16
Abstract: The mattress has a protective cover (1) with an opening (3) near one end in at least one side, making a pouch to receive a pillow. The cover can have a pouch for a pillow in both sides for when the mattress is turned, with the second pouch at the opposite end of the mattress to the first.
Patent EP-1250147-B1 (EP)
Inventor: SANCEAU JOSIANE
IPC: A61K38/21
Filed: 2001-01-18
Granted: 2004-04-28
Abstract: The invention relates to the use of interferon-alpha for the treatment of Ewing's family of tumors in mammals. A method of treating Ewing's family of tumors in a mammal comprising administering to the mammal in need of such treatment a therapeutically effective amount of interferon-alpha is disclosed. The present invention further relates to pharmaceutical compositions suitable for administration to a mammal for the treatment of Ewing's family of tumors comprising interferon-alpha in a therapeutically effective amount, together with a pharmaceutically acceptable carrier.
Patent EP-1273128-B1 (EP)
Inventor: HAVERINEN HENRY
IPC: G06F21/44
Filed: 2001-01-08
Granted: 2005-11-09
Abstract: Authentication method for authenticating a mobile node to a packet data network, in which a shared secret for both the mobile node and the packet data network is arranged by using a shared secret of the mobile node and a telecommunications network authentication centre. In the method, the mobile node sends its subscriber identity to the packet data network together with a replay attack protector. The packet data network obtains authentication triplets, forms a session key using them, and sends back to the mobile node challenges and a cryptographic authenticator made by using the session key. The mobile node can then form the rest of the authentication triplets using the challenges and then form the session key. With the session key, the mobile node can check the validity of the cryptographic authenticator. If the authenticator is correct, the mobile node sends a cryptographic response formed using the session key to the packet data network for authenticating itself to the packet data network.
Patent EP-1256575-B1 (EP)
Inventor: TSUSHIMA MASAKI
IPC: A61K31/445
Filed: 2001-02-16
Granted: 2005-08-17
Abstract: A medicament useful for preventive and/or therapeutic treatment of nerve system diseases which comprises, as an active ingredient, a compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof: <CHEM> wherein, X represents a group represented by the following general formula (II), (III), (IV), (V), or (VI), <CHEM> "A" represents a saturated or unsaturated 3- to 6-membered carbocyclic group and the like, "B" represents CH2 and the like, "n" represents 0 to 2, R<1> represents a hydrogen atom, a halogen atom and the like, R<2>, R<3>, and R<7> to R<14> represent a hydrogen atom, a lower alkyl group which may be substituted and the like, R<4> represents a hydrogen atom, a lower alkyl group which may be substituted and the like, R<5> represents a hydrogen atom, a halogen atom and the like, R<6> represents a saturated or unsaturated monocyclic or bicyclic carbocyclic group and the like, and R<5> and R<6>, R<7> and R<8>, R<9> and R<10>, or R<11> and R<12> may bind to each other to form a cyclic structure.
Patent EP-1266194-B1 (EP)
Inventor: D ANGELICO SASCHA
IPC: G01F23/296
Filed: 2001-02-09
Granted: 2011-04-06
Abstract: The invention relates to a method and an apparatus for establishing and/or monitoring the filling level of a medium in a container and to the determination of the density of a medium in a container.It is the object of the invention to propose a method and an apparatus which permit reliable determination and/or monitoring of the filling level or the density of a medium.With reference to the apparatus according to the invention, the object is achieved by virtue of the fact that at least a first mode and a second mode of the oscillations of the oscillable unit (2) are evaluated, and the evaluated modes are used to detect a change in mass at the oscillable unit (2).
Patent EP-1263753-B1 (EP)
Inventor: STEADMAN JON GRAHAM
IPC: A61P25/00
Filed: 2001-03-02
Granted: 2004-05-06
Abstract: Compounds of formula (I): wherein X is O, CH<SUB>2</SUB>, S or NH, or the moiety X-R<SUP>1 </SUP>is hydrogen; V is CH or N; R<SUP>1 </SUP>is hydrogen, C<SUB>1-6</SUB>alkyl, C<SUB>3-7</SUB>cycloalkyl, aryl, arylC<SUB>1-6</SUB>alkyl, heterocyclyl, heterocyclylC<SUB>1-6</SUB>alkyl, heteroaryl, or heteroarylC<SUB>1-6</SUB>alkyl any of which except for hydrogen may be optionally substituted; R<SUP>2 </SUP>and R<SUP>3 </SUP>independently represent optionally substituted C<SUB>1-6</SUB>alkyl, or R<SUP>2 </SUP>and R<SUP>3 </SUP>together with the carbon atom to which they are attached form an optionally substituted C<SUB>3-7</SUB>cycloalkyl or C<SUB>3-7</SUB>cycloalkenyl ring; or R<SUP>2 </SUP>and R<SUP>3 </SUP>together with the carbon atom to which they are attached form an optionally substituted 5 to 7-membered heterocyclyl ring containing up to 3 heteroatoms selected from N, O, S.R<SUP>4 </SUP>and R<SUP>5 </SUP>independently represent hydrogen, C<SUB>1-6</SUB>alkyl, C<SUB>3-7</SUB>cycloalkyl, aryl, arylC<SUB>1-6</SUB>alkyl, heteroaryl, heteroarylC<SUB>1-6</SUB>alkyl, heterocyclyl, or heterocyclylC<SUB>1-6</SUB>alkyl, any of which except for hydrogen may be optionally substituted or R<SUP>4 </SUP>and R<SUP>5 </SUP>together with the nitrogen atom to which they are attached form 4- to 8-membered ring; Ar is an aryl or heteroaryl ring either of which may be optionally substituted; one of X<SUB>1 </SUB>and X<SUB>2 </SUB>is N and the other is NR<SUP>6</SUP>, wherein R<SUP>6 </SUP>is hydrogen, C<SUB>1-6</SUB>alkyl, or arylC<SUB>1-6</SUB>alkyl or pharmaceutically acceptable salts thereof, their use as inhibitors of Raf kinases, and pharmaceutical compositions containing them.
Patent EP-1257493-B1 (EP)
Inventor: BOUVERESSE JEAN-ANTIDE
IPC: B65H37/00
Filed: 2001-02-12
Granted: 2005-05-25
Abstract: The invention relates to a hand-held device (1) for transferring a film (4) of for example adhesive, covering or coloured material from a supply onto a substrate (5), comprising a base body (2), on which the supply and an application member (3) are disposed, a cover (14) being provided for the application member (3) which is moveable between a covering position covering the application member (3) and a release position releasing the application member (3). With a view to reducing the amount of space required by the hand-held device (1), the direction of movement (14a) substantially follows the outer contour of the base body (2).
Patent EP-1290674-B1 (EP)
Inventor: SUNDSTROEM JARI
IPC: G10D9/00
Filed: 2001-04-12
Granted: 2006-07-05
Abstract: The handrest facilitates the supporting of musical instruments and similar objects. When the player supports a musical instrument over long periods of times, the tendon between his thumb and wrist will be susceptible to tenosynovitis and the edge of his thumb will grow a callus. A handrest consisting of the parts (1-6) shown in figure 1 shifts the weight of the object to be supported from the thumb to the area between the thumb and the index finger. The control members allow the handrest to be adapted to different hand sizes and playing styles. The use of a handrest allows longer practising periods and more rapid and sensitive fingering.
Patent EP-1276504-B1 (EP)
Inventor: DECAUDIN DIDIER
IPC: A61K31/5513
Filed: 2001-04-27
Granted: 2005-01-26
Abstract: The invention concerns the use of Ro5-4864, and compounds derived therefrom, for preparing medicines for treating tumoral pathologies. The invention also concerns said compounds combined with an apoptosis-inducing agent, as combination products for simultaneous, separate or prolonged use, in cancer therapy.
Patent EP-1297205-B1 (EP)
Inventor: ZHU REIYAO
IPC: D04B1/22
Filed: 2001-06-12
Granted: 2005-04-27
Abstract: The present invention relates to a comfortable, cut resistant and abrasion resistant, composition composed of cotton, nylon, and p-aramid fibers and used primarily in the sheath for sheath/core yarns in protective apparel.
Patent EP-1295101-B1 (EP)
Inventor: BEDINGHAM WILLIAM
IPC: G01N1/00
Filed: 2001-06-28
Granted: 2013-12-18
Abstract: Methods and devices for thermal processing of multiple samples at the same time are disclosed. The assemblies include carriers and sample processing devices with process arrays that include conduits useful in distributing sample materials to a group of process chambers located in fluid communication with the main conduits. The sample processing devices may include one or more of the following features in various combinations: deformable seals, process chambers connected to the main conduit by feeder conduits exciting the main conduit at offset locations, U-shaped loading chambers, and a combination of melt bonded and adhesively bonded areas. The carriers may be used to apply selective compression to the sample processing devices.